# EDGAR Filing Document

**Accession Number:** 0001586094
**File Stem:** 0001539497-25-003053
**Filing Date:** 2025-11
**Character Count:** 16866
**Document Hash:** 6ced62c3165dbf5302675c9dcee4c9bc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001539497-25-003053.hdr.sgml**: 20251124

**ACCESSION NUMBER**: 0001539497-25-003053

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251124

**DATE AS OF CHANGE**: 20251124

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Acadia Healthcare Company, Inc.
- **CENTRAL INDEX KEY:** 0001520697
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-86704
- **FILM NUMBER:** 251514686

**BUSINESS ADDRESS:**
- **STREET 1:** 6100 TOWER CIRCLE
- **STREET 2:** SUITE 1000
- **CITY:** FRANKLIN
- **STATE:** TN
- **ZIP:** 37067
- **BUSINESS PHONE:** 615-861-6000

**MAIL ADDRESS:**
- **STREET 1:** 6100 TOWER CIRCLE
- **STREET 2:** SUITE 1000
- **CITY:** FRANKLIN
- **STATE:** TN
- **ZIP:** 37067
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Khrom Investments Fund, LP
- **CENTRAL INDEX KEY:** 0001586094

**ORGANIZATION NAME:**
- **EIN:** 371620114
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 1691 MICHIGAN AVE
- **STREET 2:** SUITE 240
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33139
- **BUSINESS PHONE:** 646-436-6643

**MAIL ADDRESS:**
- **STREET 1:** 1691 MICHIGAN AVE
- **STREET 2:** SUITE 240
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33139

## Ex-1

**<u>EXHIBIT 1</u>**

**TRANSACTIONS IN SHARES**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp; **<u>Khrom Investments Fund, LP</u>** | &nbsp;&nbsp; **<u>Khrom Investments Fund, LP</u>** | &nbsp;&nbsp; **<u>Khrom Investments Fund, LP</u>** | &nbsp;&nbsp; **<u>Khrom Investments Fund, LP</u>** |
| &nbsp;&nbsp;**<u>Date</u>** | &nbsp;&nbsp;**<u>Nature of Transaction</u>** | &nbsp;&nbsp;**<u>Number of Shares</u>** | &nbsp;&nbsp;**<u>Price Per Share ($)</u>** |
| &nbsp;&nbsp;10/10/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;44000 | &nbsp;&nbsp;24.369 |
| &nbsp;&nbsp;10/20/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;3000 | &nbsp;&nbsp;24.1906 |
| &nbsp;&nbsp;10/20/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;1000 | &nbsp;&nbsp;24.2759 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;23.6212 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;5000 | &nbsp;&nbsp;23.82 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;4000 | &nbsp;&nbsp;23.775 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;16000 | &nbsp;&nbsp;23.8013 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;3000 | &nbsp;&nbsp;23.85 |
| &nbsp;&nbsp;10/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;2000 | &nbsp;&nbsp;23.65 |
| &nbsp;&nbsp;10/22/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;50000 | &nbsp;&nbsp;23.3996 |
| &nbsp;&nbsp;10/23/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;45000 | &nbsp;&nbsp;23.7664 |
| &nbsp;&nbsp;10/23/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;6618 | &nbsp;&nbsp;23.8094 |
| &nbsp;&nbsp;10/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;14461 | &nbsp;&nbsp;23.53 |
| &nbsp;&nbsp;10/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;2000 | &nbsp;&nbsp;23.5736 |
| &nbsp;&nbsp;10/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;3749 | &nbsp;&nbsp;23.3415 |
| &nbsp;&nbsp;10/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;8500 | &nbsp;&nbsp;23.4206 |
| &nbsp;&nbsp;10/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;3000 | &nbsp;&nbsp;23.7806 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;5000 | &nbsp;&nbsp;23.3809 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;20000 | &nbsp;&nbsp;23.32 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;42000 | &nbsp;&nbsp;23.3642 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;23.3801 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;23.3653 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;23.115 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;26707 | &nbsp;&nbsp;23.4711 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;42000 | &nbsp;&nbsp;23.5034 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;22.8454 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;2000 | &nbsp;&nbsp;23.2558 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;16699 | &nbsp;&nbsp;23.4336 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;30000 | &nbsp;&nbsp;22.9748 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;30000 | &nbsp;&nbsp;23.027 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;22.8548 |
| &nbsp;&nbsp;10/27/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;30000 | &nbsp;&nbsp;23.0012 |
| &nbsp;&nbsp;10/28/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;20000 | &nbsp;&nbsp;22.9862 |
| &nbsp;&nbsp;10/28/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;10000 | &nbsp;&nbsp;22.997 |
| &nbsp;&nbsp;10/30/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;26000 | &nbsp;&nbsp;22.217 |
| &nbsp;&nbsp;10/30/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;18000 | &nbsp;&nbsp;22.3469 |
| &nbsp;&nbsp;10/30/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;150000 | &nbsp;&nbsp;22.1497 |
| &nbsp;&nbsp;10/30/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;8000 | &nbsp;&nbsp;22.1602 |
| &nbsp;&nbsp;11/3/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;65471 | &nbsp;&nbsp;21.0677 |
| &nbsp;&nbsp;11/7/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;45073 | &nbsp;&nbsp;19.1493 |
| &nbsp;&nbsp;11/20/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;250000 | &nbsp;&nbsp;14.5331 |
| &nbsp;&nbsp;11/20/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;36067 | &nbsp;&nbsp;14.3803 |
| &nbsp;&nbsp;11/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;3037 | &nbsp;&nbsp;14.457 |
| &nbsp;&nbsp;11/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;300000 | &nbsp;&nbsp;15.2559 |
| &nbsp;&nbsp;11/21/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;53481 | &nbsp;&nbsp;14.8481 |
| &nbsp;&nbsp;11/24/2025 | &nbsp;&nbsp;Open market purchase | &nbsp;&nbsp;600000 | &nbsp;&nbsp;15.379 |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Acadia Healthcare Company, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**00404A109**

*(CUSIP Number)*

**Eduard Skutelsky**<br>COO of Khrom Capital Management LLC<br>1691 Michigan Ave., Suite 240<br>Miami FL 33139<br>(646) 436-6643

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/20/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **00404A109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Khrom Investments Fund, LP** | Name of reporting person<br>**Khrom Investments Fund, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**7138311.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**7138311.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7138311.00** | Aggregate amount beneficially owned by each reporting person<br>**7138311.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.74%** | Percent of class represented by amount in Row (11)<br>**7.74%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **00404A109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Khrom Capital Management LLC** | Name of reporting person<br>**Khrom Capital Management LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**NEW YORK** | Citizenship or place of organization<br>**NEW YORK** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7138311.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7138311.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7138311.00** | Aggregate amount beneficially owned by each reporting person<br>**7138311.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.74%** | Percent of class represented by amount in Row (11)<br>**7.74%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **00404A109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Eric Khrom** | Name of reporting person<br>**Eric Khrom** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**FLORIDA** | Citizenship or place of organization<br>**FLORIDA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6928.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7138311.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6928.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7138311.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7145239.00** | Aggregate amount beneficially owned by each reporting person<br>**7145239.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.74%** | Percent of class represented by amount in Row (11)<br>**7.74%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
Acadia Healthcare Company, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
6100 TOWER CIRCLE, SUITE 1000, FRANKLIN, TN, 37067

This statement constitutes Amendment No. 1 to the Schedule 13D relating to the shares of common stock, par value $0.01 per share (the "Shares"), issued by Acadia Healthcare Company, Inc. (the "Issuer") and amends the Schedule 13D relating to the Shares filed on October 1, 2025 (the "Original 13D") by the Reporting Persons. Capitalized terms used herein and not otherwise defined have the respective meanings ascribed thereto in the Original 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The responses of the Reporting Persons to Rows (7) through (11) of the cover pages of this Schedule 13D are incorporated herein by reference. The percentages set forth on the cover pages are based on 92,258,166 outstanding Shares as of November 4, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2025. Khrom Investments is the direct beneficial owner of 7,138,311 Shares and Mr. Khrom is the direct beneficial owner of 6,928 Shares. The Shares reported as beneficially owned by Khrom Capital reflect the Shares that are directly beneficially owned by its affiliate, Khrom Investments, as Khrom Capital has the power to vote or direct the vote of (and the power to dispose or direct the disposition of) such Shares. Mr. Khrom is the sole member of Khrom Capital GP, LLC, which is the general partner of Khrom Investments. Mr. Khrom in his capacity as the managing member of Khrom Capital and as the sole member of Khrom Capital GP, LLC may be deemed to share the power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Shares directly beneficially owned by Khrom Investments and, accordingly, Mr. Khrom may be deemed to be the beneficial owner of such Shares. Mr. Khrom disclaims beneficial ownership of the Shares directly held by Khrom Investments except to the extent of any pecuniary interest therein.

**(b)**
The information set forth in Item 5(a) is incorporated into this Item 5(b).

**(c)**
Exhibit 1 attached hereto sets forth all transactions with respect to the Shares by any Reporting Person since October 1, 2025 (the date on which the Original 13D was filed).

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Khrom Investments Fund, LP

**Signature:** /s/ Eduard Skutelsky

**Name/Title:** Eduard Skutelsky / Chief Operating Officer

**Date:** 11/24/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Khrom Capital Management LLC

**Signature:** /s/ Eduard Skutelsky

**Name/Title:** Eduard Skutelsky / Chief Operating Officer

**Date:** 11/24/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Eric Khrom

**Signature:** /s/ Eric Khrom

**Name/Title:** Eric Khrom

**Date:** 11/24/2025